Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 14394-56-0 | MDL No. : | MFCD09991585 |
Formula : | C5H6ClN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JCIGQYDCSFFHPI-UHFFFAOYSA-N |
M.W : | 143.57 | Pubchem ID : | 21934626 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 36.41 |
TPSA : | 51.8 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.34 cm/s |
Log Po/w (iLOGP) : | 1.41 |
Log Po/w (XLOGP3) : | 1.18 |
Log Po/w (WLOGP) : | 1.03 |
Log Po/w (MLOGP) : | 0.33 |
Log Po/w (SILICOS-IT) : | 1.31 |
Consensus Log Po/w : | 1.05 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.97 |
Solubility : | 1.55 mg/ml ; 0.0108 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.86 |
Solubility : | 1.97 mg/ml ; 0.0137 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.27 |
Solubility : | 0.766 mg/ml ; 0.00533 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With ammonia In methanol at 140℃; for 0.666667 h; | A mixture of 4,6-dichloro-5-methylpyrimidine (available from Sigma-Aldrich No.595446) (5 g, 30.70 mmol) in ammonia (7 M solution in MeOH, 15 ml, 105 mmol) was left under stirring for 40 min in a sealed vial at 140 0C. Water (300 ml) and EtOAc (600 ml) were added to the resulting white suspension and the two layers were separated. The aqueous phase was extracted with EtOAc (3 x 600 ml). The collected organic phases were dried (Na2SO4), filtered and concentrated under reduced pressure to give the title compound D3 (3.10 g, 20.73 mmol, 68percent yield) as a white solid. UPLC: rt = 0.41 min, peaks observed: 144 (M+l, 100percent) and 146 (M+ 1, 33percent). C5H6ClN3 requires 143. 1H NMR (400 MHz, DMSO- d6) δ(ppm): 8.06 (s, 1 H), 7.09 (bs, 2 H), 2.07 (s, 3 H). |
[ 18260-92-9 ]
6-Chloro-2,5-dimethylpyrimidin-4-amine
Similarity: 0.89
[ 60025-09-4 ]
4-Amino-6-chloropyrimidine-5-carbonitrile
Similarity: 0.86
[ 98134-36-2 ]
6-Chloro-2-ethylpyrimidin-4-amine
Similarity: 0.81
[ 16372-08-0 ]
4-Chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
Similarity: 0.78
[ 18260-92-9 ]
6-Chloro-2,5-dimethylpyrimidin-4-amine
Similarity: 0.89
[ 60025-09-4 ]
4-Amino-6-chloropyrimidine-5-carbonitrile
Similarity: 0.86
[ 98134-36-2 ]
6-Chloro-2-ethylpyrimidin-4-amine
Similarity: 0.81
[ 65766-32-7 ]
6-Chloro-N-methylpyrimidin-4-amine
Similarity: 0.78
[ 18260-92-9 ]
6-Chloro-2,5-dimethylpyrimidin-4-amine
Similarity: 0.89
[ 60025-09-4 ]
4-Amino-6-chloropyrimidine-5-carbonitrile
Similarity: 0.86
[ 98134-36-2 ]
6-Chloro-2-ethylpyrimidin-4-amine
Similarity: 0.81
[ 65766-32-7 ]
6-Chloro-N-methylpyrimidin-4-amine
Similarity: 0.78